SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 76.44 |
| Enterprise Value ($M) | 56.42 |
| Book Value ($M) | 21.05 |
| Book Value / Share | 0.14 |
| Price / Book | 3.63 |
| NCAV ($M) | 9.75 |
| NCAV / Share | 0.07 |
| Price / NCAV | 7.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.49 |
| Return on Assets (ROA) | -0.51 |
| Return on Equity (ROE) | -0.80 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.80 |
| Current Ratio | 3.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 21.38 |
| Assets | 32.67 |
| Liabilities | 11.62 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 16.89 |
| Operating Income | -38.14 |
| Net Income | -37.80 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -21.68 |
| Cash from Investing | 0.15 |
| Cash from Financing | 36.83 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Adage Capital Partners Gp, L.l.c. | 1.57 | -83.24 | |
| 13G/A | Adage Capital Management, L.P. | 5.37 | ||
| 13G | BlackRock, Inc. | 5.60 | 0.00 | |
| 13G/A | Millennium Management Llc | 4.00 | -22.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 203,365 | 749,884 | 27.12 | |
| 191,140 | 561,217 | 34.06 | |
| 233,439 | 808,958 | 28.86 | |
| 257,884 | 797,962 | 32.32 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| UNCY – Unicycive Therapeutics, Inc. | UPC – Universe Pharmaceuticals INC |
| UPXI – Upexi, Inc. | VIVS – VivoSim Labs, Inc. |
| VKTX – Viking Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io